SCHEMBL9517201

SCHEMBL9517201

COc1ccc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)c3ccc(COC(=O)c4ccccc4C)nc3)cc2)cc1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.52
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
ALDH1A1 P00352 2/20 0.48
MAPT P10636 2/20 0.48
CYSLTR1 Q9Y271 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
MAPK1 P28482 1/20 0.44
ADRB2 P07550 1/20 0.44
ADRB1 P08588 1/20 0.44
ADRB3 P13945 1/20 0.44
CNR2 P34972 1/20 0.44
NLRP3 Q96P20 1/20 0.44
ROCK2 O75116 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9517352 0.93 LMNA (0.49) TSHRALDH1A1CYSLTR1CNR2
SCHEMBL9519208 0.86 P4HTM (0.39) ALDH1A1MAPTCYSLTR1CA1CA2
SCHEMBL9515903 0.86 NPC1 (0.51) NPC1RAB9AALDH1A1MAPTCYSLTR1
SCHEMBL9516064 0.85 TSHR (0.62) TSHRNPC1RAB9AALDH1A1MAPT
SCHEMBL9517246 0.82 CNR2 (0.53) TSHRNPC1RAB9AALDH1A1MAPT
SCHEMBL9519167 0.82 CNR2 (0.53) TSHRNPC1RAB9AALDH1A1MAPT
SCHEMBL9515933 0.82 P4HTM (0.55) TSHRALDH1A1MAPT
SCHEMBL9517969 0.81 EPHX2 (0.44) TSHRRAB9AALDH1A1MAPTNLRP3
SCHEMBL8867585 0.80 NLRP3 (0.57) TSHRALDH1A1MAPTNLRP3CYP3A4
SCHEMBL9519304 0.80 CA1 (0.55) TSHRALDH1A1MAPTCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed